- Filed
- Aug 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 62.23M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 61.69M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 60.28M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 59.5M sh |
| Stock Repurchased | Q2 2025 · Jun 30, 2025 | $72.55M |
| Stock Repurchased | Q2 2025 · Jun 30, 2024 | $0 |
| Dividends Paid | Q2 2025 · Jun 30, 2025 | $94.95M |
| Dividends Paid | Q2 2025 · Jun 30, 2024 | $83.53M |
| Capex | Q2 2025 · Jun 30, 2025 | $201.84M |
| Capex | Q2 2025 · Jun 30, 2024 | $97.35M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | $305.91M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2024 | $279.22M |
| Long Term Debt | Q2 2025 · Jun 30, 2025 | $3.77B |
| Long Term Debt | Q2 2025 · Dec 31, 2024 | $3.39B |
| Cash And Equivalents | Q2 2025 · Jun 30, 2025 | $10.73M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $3.61M |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | −$1.57B |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | −$2.55B |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | −$2.98B |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | −$1.21B |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | −$973.44M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | −$530.82M |
| Current Liabilities | Q2 2025 · Jun 30, 2025 | $501.82M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $418.55M |
| Total Liabilities | Q2 2025 · Jun 30, 2025 | $4.34B |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $3.84B |
| Current Assets | Q2 2025 · Jun 30, 2025 | $312.63M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $294.76M |
| Total Assets | Q2 2025 · Jun 30, 2025 | $7.15B |
| Total Assets | Q2 2025 · Dec 31, 2024 | $6.81B |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | $0.33 |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | $0.38 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | $0.54 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | $0.67 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | $0.33 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | $0.38 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | $0.54 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | $0.68 |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $24.24M |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $61.84M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $31.09M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $65.23M |
| Net Income | Q2 2025 · Jun 30, 2025 | $23.65M |
| Net Income | Q2 2025 · Jun 30, 2025 | $29.78M |
| Net Income restated | Q2 2025 · Jun 30, 2024 | $37.19M |
| Net Income restated | Q2 2025 · Jun 30, 2024 | $48.74M |
| Operating Income | Q2 2025 · Jun 30, 2025 | $77.46M |
| Operating Income | Q2 2025 · Jun 30, 2025 | $96.74M |
| Operating Income | Q2 2025 · Jun 30, 2024 | $56.59M |
| Operating Income | Q2 2025 · Jun 30, 2024 | $82.69M |
| Revenue | Q2 2025 · Jun 30, 2025 | $426.74M |
| Revenue | Q2 2025 · Jun 30, 2025 | $870M |
| Revenue | Q2 2025 · Jun 30, 2024 | $359.46M |
| Revenue | Q2 2025 · Jun 30, 2024 | $700.85M |